Volume 91, Issue 5, Pages (May 2017)

Slides:



Advertisements
Similar presentations
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Advertisements

Volume 82, Issue 12, Pages (December 2012)
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 54, Issue 2, Pages (August 1998)
Nutrition and chronic kidney disease
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study 
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Volume 63, Issue 1, Pages (January 2003)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients  G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,
Volume 64, Pages S3-S12 (December 2003)
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
C-reactive protein and dialysis access
Volume 64, Issue 3, Pages (September 2003)
IP155. Transplant Wait Listing Attenuates the Association Between Hemodialysis Access and Mortality  Courtenay Holscher, Sunjae Bae, Christine Haugen,
Type of vascular access and mortality in U.S. hemodialysis patients
Volume 93, Issue 5, Pages (May 2018)
Volume 80, Issue 2, Pages (July 2011)
Volume 82, Issue 12, Pages (December 2012)
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Volume 88, Issue 2, Pages (August 2015)
M. Kraemer, C. Rode, V. Wizemann  Kidney International 
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Volume 82, Issue 1, Pages (July 2012)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Volume 76, Issue 10, Pages (November 2009)
Volume 67, Issue 6, Pages (June 2005)
Nutrition and chronic kidney disease
Volume 91, Issue 5, Pages (May 2017)
Volume 86, Issue 4, Pages (October 2014)
Volume 84, Issue 1, Pages (July 2013)
Volume 68, Issue 5, Pages (November 2005)
Volume 77, Issue 7, Pages (April 2010)
Volume 88, Issue 5, Pages (November 2015)
Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study  K.O. Gradel, R.W. Thomsen, S.
Statins and other agents for vascular inflammation
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
U-shaped effect of eGFR and mortality
Body size and outcomes on peritoneal dialysis in the United States
Volume 69, Issue 10, Pages (May 2006)
The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying  Charles Chazot, Guillaume Jean  Kidney.
Volume 76, Issue 6, Pages (September 2009)
Prevention of biofilm formation in dialysis water treatment systems
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Volume 83, Issue 2, Pages (February 2013)
Volume 71, Issue 6, Pages (March 2007)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
David A. Goodkin, MD, Eric W
Volume 58, Issue 1, Pages (July 2000)
Volume 72, Issue 4, Pages (August 2007)
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 82, Issue 3, Pages (August 2012)
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S.
Volume 57, Issue 4, Pages (April 2000)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Volume 61, Issue 2, Pages (February 2002)
Current status of maintenance hemodialysis in Beijing, China
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Volume 72, Issue 2, Pages (July 2007)
Volume 61, Issue 1, Pages (January 2002)
Volume 75, Issue 1, Pages (January 2009)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Volume 87, Issue 3, Pages (March 2015)
Sushrut S. Waikar, MD, MPH, Gary C. Curhan, MD, ScD, Steven M
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Volume 91, Issue 5, Pages 1214-1223 (May 2017) Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort  Marijke J.E. Dekker, Daniele Marcelli, Bernard J. Canaud, Paola Carioni, Yuedong Wang, Aileen Grassmann, Constantijn J.A.M. Konings, Peter Kotanko, Karel M. Leunissen, Nathan W. Levin, Frank M. van der Sande, Xiaoling Ye, Vaibhav Maheshwari, Len A. Usvyat, Jeroen P. Kooman  Kidney International  Volume 91, Issue 5, Pages 1214-1223 (May 2017) DOI: 10.1016/j.kint.2016.12.008 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 Study design. For this study we included patients of the European subset of the MONDO Initiative database, with at least 1 multifrequency bioimpedance spectroscopy (MF-BIS) measurement in the year 2011. The last MF-BIS measurement of this year was used as an anchor point. All MF-BIS measurements (including the last 1 of 2011), dialysis characteristics, and laboratory values of the 3 months prior to this last MF-BIS measurement were used to calculate the averages of baseline period 1. The same parameters of the 3 months after the last MF-BIS measurement in 2011 were used to calculate the averages of period 2. A comparison of the study cohort and excluded patients revealed that excluded patients were younger (64 vs. 66 years; P < 0.001), more frequently diabetic (19.9% vs. 17.7%; P < 0.001), and had a higher prevalence of catheter as dialysis access (23.6% vs. 15.6%, P < 0.001). The difference in body mass index was not statistically significant. C-reactive protein (CRP) levels were higher (median: 6.4 mg/l [2.60–15.80] vs. 5.2 mg/l [2.30–11.57]; P < 0.001). Predialysis fluid status was lower in the excluded patients (median +1.57 L [0.59–2.62] vs. +1.71 L [0.88–2.62]; P < 0.001). For more details, see the Supplemental Material A, a comparison between the study cohort and the excluded patient cohort. *No data available due to transfer to other clinics, kidney transplantation, modality switch, no reason for unavailable CRP, or MF-BIS measurements. **Predialysis fluid depletion was defined as the predialysis “overhydration” compartment reported below –1.1 L. Kidney International 2017 91, 1214-1223DOI: (10.1016/j.kint.2016.12.008) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 2 Survival curve of the adjusted hazard ratios for mortality in patient groups stratified by (a) predialysis and (b) postdialysis fluid status. Survival probabilities and hazard ratios (HR) from a Cox proportional hazards model adjusted for age, gender, dialysis vintage, access type (arteriovenous vs. catheter access), region, body mass index, normalized protein catabolic rate, ultrafiltration rate (<10 ml/h/kg, 10–13 ml/h/kg, or >13 ml/h/kg), diabetes mellitus, congestive heart failure, peripheral vascular disease, cerebrovascular disease, and the presence of a malignancy. (a) Fluid depletion (N = 239), HR: 2.03 (95% CI: 1.32–3.12); moderate fluid overload (N = 3444), HR: 1.64 (95% CI: 1.35–1.98); severe fluid overload (N = 2083), HR: 2.74 (95% CI: 2.25–3.35); extreme fluid overload (N = 356), HR: 4.23 (95% CI: 3.16–5.65). The reference group is patients with predialysis normovolemia (>–1.1 L to +1.1 L) (N = 2761). (b) Fluid depletion (N = 4693), HR: 0.74 (95% CI: 0.62–0.90); moderate fluid overload (N = 1047), HR: 1.72 (95% CI: 1.45–2.05); severe fluid overload (N = 370), HR: 2.62 (95% CI: 2.09–3.34); extreme fluid overload (N = 108), HR: 3.22 (95% CI: 2.16–4.80). Reference group are patients with postdialysis normovolemia (>–1.1 L to +1.1 L) (N = 2665). Kidney International 2017 91, 1214-1223DOI: (10.1016/j.kint.2016.12.008) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 3 Relation between pre- and postdialysis fluid status. The percentage of patients with a particular postdialysis fluid status stratified by predialysis fluid status. Kidney International 2017 91, 1214-1223DOI: (10.1016/j.kint.2016.12.008) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 4 Patients stratified by inflammation and predialysis fluid status. Dynamics of fluid status and inflammation (I) in the subset analysis. FO+ = predialysis > +2.5 L fluid overload (FO); FO– = predialysis fluid status > –1.1 L and < +2.5 L; I+ = C-reactive protein > 6.0 mg/L; I– = C-reactive protein ≤ 6.0 mg/L. Kidney International 2017 91, 1214-1223DOI: (10.1016/j.kint.2016.12.008) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 5 Dynamics of fluid status and inflammation and survival during 6-month follow-up. Surival probabilities and hazard ratios from a Cox proportional hazards model adjusted for age, gender, dialysis vintage, access type (arteriovenous vs. catheter access), region, body mass index, normalized protein catabolic rate, ultrafiltration rate (<10 ml/h/kg, 10–13 ml/h/kg, or >13 ml/h/kg), diabetes mellitus, congestive heart failure, peripheral vascular disease, cerebrovascular disease, and present malignancy. Kidney International 2017 91, 1214-1223DOI: (10.1016/j.kint.2016.12.008) Copyright © 2016 International Society of Nephrology Terms and Conditions